105 filings
Page 5 of 6
8-K
4j3gldpl z9pi
15 Dec 05
Roche and Maxygen to Co-Develop Recombinant Factor
12:00am
8-K
g351u17vx6v
12 Dec 05
Maxygen Appoints Louis G. Lange to Its Board of Directors
12:00am
8-K
kerjfeu8m9oo94docrwv
30 Nov 05
Entry into a Material Definitive Agreement
12:00am
8-K
sbse4 zdtg0j1oxgjc
25 Oct 05
Maxygen Reports Third Quarter 2005 Financial Results
12:00am
8-K
znxfcnhyef5me307 l4
26 Jul 05
Maxygen Reports Second Quarter 2005 Financial Results
12:00am
8-K
g0iblgvb
17 Jun 05
Maxygen Consolidates to Focus Resources on Product Development
12:00am
8-K
55pw3lmfkd
26 Apr 05
Maxygen Reports First Quarter 2005 Financial Results
12:00am
8-K
awwr4a8q9funr
24 Mar 05
Entry into a Material Definitive Agreement
12:00am
8-K
fsd d266iz954
8 Feb 05
Maxygen Reports Fourth Quarter and Year End 2004 Financial Results
12:00am
8-K
5sp2g0ipcy802ia 14
7 Feb 05
Entry into a Material Definitive Agreement
12:00am
8-K
tivnhnu433 fu123wx8q
16 Dec 04
Entry into a Material Definitive Agreement
12:00am
8-K
x2tjlpf6emf3w
13 Dec 04
Entry into a Material Definitive Agreement
12:00am
8-K
sg0oj7n
26 Oct 04
Maxygen Reports Third Quarter 2004 Financial Results
12:00am
8-K
gxb1ezy0la6w8as77yx
27 Jul 04
Maxygen Reports Second Quarter 2004 Financial Results
12:00am
8-K
d6332
20 Jul 04
Current report
12:00am
8-K
sypo2o0 iifbao
2 Jul 04
DuPont Completes Purchase of Maxygen Subsidiary Verdia
12:00am
8-K
z4d3jbxun9nee0
3 Jun 04
Other events
12:00am
8-K
05c o4ya3dy4c
7 May 04
Current Report on Form 8-K
12:00am
8-K
3qfi3 2loq
27 Apr 04
Maxygen Reports First Quarter 2004 Financial Results
12:00am
8-K
y29xhz pikuhg925b5td
10 Feb 04
Maxygen Reports Fourth Quarter and Year End 2003 Financial Results
12:00am